SCHEMBL23937886

SCHEMBL23937886

Cc1nn(O)c2c1CCC2

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.44
L3MBTL1 Q9Y468 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.39
HTT P42858 1/20 0.34
ALDH1A1 P00352 3/20 0.33
RAB9A P51151 3/20 0.33
NPC1 O15118 2/20 0.33
HPGD P15428 1/20 0.33
KMT2A Q03164 1/20 0.33
HSD17B10 Q99714 1/20 0.33
HCRTR1 O43613 1/20 0.32
GAA P10253 1/20 0.32
MAPK1 P28482 1/20 0.32
PARP1 P09874 2/20 0.32
LMNA P02545 1/20 0.31
HTR6 P50406 2/20 0.30
HTR2B P41595 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23937901 0.96 KDM4E (0.41) KDM4EL3MBTL1SMN1; SMN2HTTALDH1A1
SCHEMBL13159948 0.76 KDM4E (0.46) KDM4EL3MBTL1SMN1; SMN2HTTALDH1A1
SCHEMBL20631145 0.74 LMNA (0.30) KDM4ELMNA
SCHEMBL20631148 0.74 PTGS2 (0.32) KDM4E
SCHEMBL19312297 0.74 KDM4E (0.44) KDM4EL3MBTL1SMN1; SMN2HTTALDH1A1
SCHEMBL23937897 0.72 PARP1 (0.33) PARP1
SCHEMBL14752475 0.71 PARP1 (0.43) KDM4EL3MBTL1SMN1; SMN2HTTALDH1A1
SCHEMBL8270929 0.71 HTT (0.62) KDM4EL3MBTL1SMN1; SMN2HTTALDH1A1
SCHEMBL20631134 0.71 KDM4E (0.42) KDM4EL3MBTL1SMN1; SMN2ALDH1A1RAB9A
SCHEMBL20631147 0.70 LMNA (0.33) KMT2AGAAMAPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3399968-B1 SELECTIVE INHIBITORS OF CLINICALLY IMPORTANT MUTANTS OF THE EGFR TYROSINE KINASE CS PHARMATECH LTD (KY) 2021-10-20 EP disclosed